{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:55:28Z","timestamp":1784336128009,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T00:00:00Z","timestamp":1534896000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s00105-018-4257-8","type":"journal-article","created":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T13:31:11Z","timestamp":1534944671000},"page":"916-921","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Skleromyx\u00f6dem","Scleromyxedema"],"prefix":"10.1007","volume":"69","author":[{"given":"M.","family":"Neufeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Sunderk\u00f6tter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. K. C.","family":"Moritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,22]]},"reference":[{"key":"4257_CR1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jaad.2013.01.007","volume":"69","author":"F Rongioletti","year":"2013","unstructured":"Rongioletti F, Merlo G, Cinotti E et\u00a0al (2013) Scleromyxedema: a\u00a0multicenter study of characteristics, comorbidities, course, and therapy in 30 patients. J\u00a0Am Acad Dermatol 69:66\u201372","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"4257_CR2","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/ijd.13429","volume":"56","author":"X Fang","year":"2017","unstructured":"Fang X, Yang B, Zhou G, Zhang F (2017) Localized lichen myxedematosus in childhood: What is the accurate diagnosis? Int J Dermatol 56(3):333\u2013336","journal-title":"Int J Dermatol"},{"key":"4257_CR3","first-page":"687","volume-title":"Dermatology","author":"F Rongioletti","year":"2012","unstructured":"Rongioletti F, Mucinoses RA (2012) Dermatology. In: Bolognia J, Jorizzo JL, Schaffer JV (Hrsg) Dermatology. 3.\u00a0Aufl. Bd. 1. Elsevier, Philadelphia, S\u00a0687","edition":"3"},{"issue":"10","key":"4257_CR4","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1093\/rheumatology\/ker209","volume":"50","author":"R Bos","year":"2011","unstructured":"Bos R, De waal EG, Kuiper H, Hazenberg BP, Vellenga E (2011) Thalidomide and dexamethasone followed by autologous stem cell transplantation for scleromyxoedema. Rheumatology 50(10):1925\u20131926","journal-title":"Rheumatology"},{"key":"4257_CR5","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.sder.2006.04.001","volume":"25","author":"F Rongioletti","year":"2006","unstructured":"Rongioletti F (2006) Lichen myxedematosus (papular mucinosis): new concepts and perspectives for an old disease. Semin Cutan Med Surg 25:100\u2013104","journal-title":"Semin Cutan Med Surg"},{"key":"4257_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0190-9622(95)90007-1","volume":"33","author":"AM Dinneen","year":"1995","unstructured":"Dinneen AM, Dicken CH (1995) Scleromyxedema. J\u00a0Am Acad Dermatol 33:37\u201343","journal-title":"J Am Acad Dermatol"},{"key":"4257_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/MD.0b013e3181630835","volume":"87","author":"M Blum","year":"2008","unstructured":"Blum M, Wigley FM, Hummers LK (2008) Scleromyxedema: a\u00a0case series highlighting long-term outcomes of treatment with intravenous immunoglobulin (IVIG). Medicine (Baltimore) 87:10\u201320","journal-title":"Medicine (Baltimore)"},{"key":"4257_CR8","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1046\/j.1365-2133.2001.04261.x","volume":"144","author":"F Rongioletti","year":"2001","unstructured":"Rongioletti F, Hazini A, Rebora A (2001) Coma associated with scleromyxedema and interferon alfa therapy. Full recovery after steroids and cyclophosphamide combined with plasmapheresis. Br J Dermatol 144:1283\u20131284","journal-title":"Br J Dermatol"},{"key":"4257_CR9","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/j.1600-0560.2012.01882.x","volume":"39","author":"KE Fleming","year":"2012","unstructured":"Fleming KE, Virmani D, Sutton E et al (2012) Scleromyxedema and the dermato-neuro syndrome: case report and review of the literature. J\u00a0Cutan Pathol 39:508\u2013517","journal-title":"J Cutan Pathol"},{"key":"4257_CR10","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.jaad.2008.11.013","volume":"60","author":"JB Rey","year":"2009","unstructured":"Rey JB, Luria RB (2009) Treatment of scleromyxedema and the dermatoneuro syndrome with intravenous immunoglobulin. J\u00a0Am Acad Dermatol 60:1037\u20131041","journal-title":"J Am Acad Dermatol"},{"key":"4257_CR11","first-page":"545","volume":"11","author":"A Espinosa","year":"1993","unstructured":"Espinosa A, De Miguel E, Morales C, Fonseca E, Gijon-Banos J (1993) Scleromyxedema associated with arthritis and myopathy: a\u00a0case report. Clin Exp Rheumatol 11:545\u2013547","journal-title":"Clin Exp Rheumatol"},{"key":"4257_CR12","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.clindermatol.2006.07.011","volume":"24","author":"CD Cokonis Georgakis","year":"2006","unstructured":"Cokonis Georgakis CD, Falasca G, Georgakis A, Heymann WR (2006) Scleromyxedema. Clin Dermatol 24:493\u2013497","journal-title":"Clin Dermatol"},{"key":"4257_CR13","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1002\/art.1780311115","volume":"31","author":"DJ Helfrich","year":"1988","unstructured":"Helfrich DJ, Walker ER, Martinez AJ, Medsger TA Jr. (1988) Scleromyxedema myopathy: case report and review of the literature. Arthritis Rheum 31:1437\u20131441","journal-title":"Arthritis Rheum"},{"key":"4257_CR14","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/j.1365-4362.1989.tb02436.x","volume":"28","author":"MJ Rothe","year":"1989","unstructured":"Rothe MJ, Rivas R, Gould E, Kerdel FA (1989) Scleromyxedema and severe myositis. Int J Dermatol 28:657\u2013660","journal-title":"Int J Dermatol"},{"key":"4257_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/09546630152607916","volume":"12","author":"F Ozdag","year":"2001","unstructured":"Ozdag F, Akar A, Eroglu E, Erbil H (2001) Acute rhabdomyolysis during the treatment of scleromyxedema with interferon alfa. J\u00a0Dermatolog Treat 12:167\u2013169","journal-title":"J Dermatolog Treat"},{"key":"4257_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1046\/j.1365-4362.2003.01565.x","volume":"42","author":"JJ Pomann","year":"2003","unstructured":"Pomann JJ, Rudner EJ (2003) Scleromyxedema revisited. Int J Dermatol 42:31\u201335","journal-title":"Int J Dermatol"},{"key":"4257_CR17","first-page":"852","volume":"20","author":"C Simone De","year":"2010","unstructured":"De Simone C, Castriota M, Carbone A, Marini Bettolo P, Pieroni M, Rongioletti F (2010) Cardiomyopathy in scleromyxedema: report of a\u00a0fatal case. Eur J Dermatol 20:852\u2013853","journal-title":"Eur J Dermatol"},{"key":"4257_CR18","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.annder.2010.08.011","volume":"137","author":"M Moigne Le","year":"2010","unstructured":"Le Moigne M, Mazereeuw-Hautier J, Bonnetblanc JM et al (2010) Clinical characteristics, outcome of scleromyxedema: a\u00a0retrospective multicenter study. Ann Dermatol Venereol 137:782\u2013788","journal-title":"Ann Dermatol Venereol"},{"key":"4257_CR19","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1177\/019459989110400312","volume":"104","author":"MF Rapp","year":"1991","unstructured":"Rapp MF, Guram M, Konrad HR, Mody N, Trapp R (1991) Laryngeal involvement in scleromyxedema: a\u00a0case report. Otolaryngol Head Neck Surg 104:362\u2013365","journal-title":"Otolaryngol Head Neck Surg"},{"key":"4257_CR20","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1097\/RHU.0b013e31822be61e","volume":"17","author":"YH Lee","year":"2011","unstructured":"Lee YH, Sahu J, O\u2019Brien MS, D\u2019Agati VD, Jimenez SA (2011) Scleroderma renal crisis-like acute renal failure associated with mucopolysaccharide accumulation in renal vessels in a\u00a0patient with scleromyxedema. J\u00a0Clin Rheumatol 17:318\u2013322","journal-title":"J Clin Rheumatol"},{"key":"4257_CR21","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/00000372-200106000-00022","volume":"23","author":"F Rongioletti","year":"2001","unstructured":"Rongioletti F, Rebora A (2001) Cutaneous mucinoses: microscopic criteria for diagnosis. Am J Dermatopathol 23:257\u2013267","journal-title":"Am J Dermatopathol"},{"key":"4257_CR22","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1067\/mjd.2001.111630","volume":"44","author":"F Rongioletti","year":"2001","unstructured":"Rongioletti F, Rebora A (2001) Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema. J\u00a0Am Acad Dermatol 44:273\u2013281","journal-title":"J Am Acad Dermatol"},{"key":"4257_CR23","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/j.1365-2133.1979.tb08080.x","volume":"100","author":"RA Hardie","year":"1979","unstructured":"Hardie RA, Hunter JA, Urbaniak S, Habeshaw JA (1979) Spontaneous resolution of lichen myxedematosus. Br J Dermatol 100:727\u2013730","journal-title":"Br J Dermatol"},{"key":"4257_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11926-011-0220-8","volume":"14","author":"J Nashel","year":"2012","unstructured":"Nashel J, Steen V (2012) Scleroderma mimics. Curr Rheumatol Rep 14:39\u201346","journal-title":"Curr Rheumatol Rep"},{"key":"4257_CR25","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1111\/jdv.14466","volume":"31","author":"R Knobler","year":"2017","unstructured":"Knobler R, Moinzadeh P, Hunzelmann N et al (2017) European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: scleromyxedema, scleredema and nephrogenic systemic fibrosis. J\u00a0Eur Acad Dermatol Venereol 31:1581\u20131594","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4257_CR26","doi-asserted-by":"publisher","first-page":"408","DOI":"10.2340\/00015555-1299","volume":"92","author":"M Bidier","year":"2012","unstructured":"Bidier M, Zschoche C, Gholam P, Enk AH, Hadaschik EN (2012) Scleromyxedema: clinical follow-up after successful treatment with high-dose immunoglobulins reveals different long-term outcomes. Acta Derm Venereol 92:408\u2013409","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"4257_CR27","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1136\/ard.61.1.59","volume":"61","author":"A Righi","year":"2002","unstructured":"Righi A, Schiavon F, Jablonska S et\u00a0al (2002) Intravenous immunoglobulins control scleromyxoedema. Ann Rheum Dis 61(1):59\u201361","journal-title":"Ann Rheum Dis"},{"key":"4257_CR28","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1126\/science.291.5503.484","volume":"291","author":"A Samuelsson","year":"2001","unstructured":"Samuelsson A, Towers TL, Ravetch JV (2001) Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 291:484\u2013486","journal-title":"Science"},{"key":"4257_CR29","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jaad.2004.01.058","volume":"51","author":"JC Sansbury","year":"2004","unstructured":"Sansbury JC, Cocuroccia B, Jorizzo JL, Gubinelli E, Gisondi P, Girolomoni G (2004) Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients. J\u00a0Am Acad Dermatol 51:126\u2013131","journal-title":"J Am Acad Dermatol"},{"key":"4257_CR30","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/j.1365-4632.2011.05030.x","volume":"52","author":"I Guarenti","year":"2013","unstructured":"Guarenti I, Sebastiani V, Pinto G, de Souza PR, de Almeida H Jr. (2013) Successful treatment of scleromyxedema with oral thalidomide. Int J Dermatol 52:631\u2013632","journal-title":"Int J Dermatol"},{"key":"4257_CR31","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/j.1468-3083.2007.02420.x","volume":"22","author":"A Martins","year":"2008","unstructured":"Martins A, Paiva Lopes MJ, Tavares Belo R, Rodrigues JC (2008) Scleromyxedema\u2014thalidomide therapy. J\u00a0Eur Acad Dermatol Venereol 22:622\u2013624","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4257_CR32","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.semarthrit.2007.10.015","volume":"38","author":"P Efthimiou","year":"2008","unstructured":"Efthimiou P, Blanco M (2008) Intravenous gammaglobulin and thalidomide may be an effective therapeutic combination in refractory scleromyxedema: case report and discussion of the literature. Semin Arthritis Rheum 38:188\u2013194","journal-title":"Semin Arthritis Rheum"},{"key":"4257_CR33","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jaad.2013.01.028","volume":"69","author":"F Brunet-Possenti","year":"2013","unstructured":"Brunet-Possenti F, Hermine O, Marinho E, Crickx B, Descamps V (2013) Combination of intravenous immunoglobulins and lenalidomide in the treatment of scleromyxedema. J\u00a0Am Acad Dermatol 69:319\u2013320","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"4257_CR34","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/ajh.25100","volume":"93","author":"J Li","year":"2018","unstructured":"Li J, Huang XF, Cai QQ, Wang C, Cai H, Zhao H, Zhang L, Cao XX, Gale RP, Zhou DB (2018) A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome. Am J Hematol 93(6):803\u2013809","journal-title":"Am J Hematol"},{"issue":"6","key":"4257_CR35","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1111\/jth.13317","volume":"14","author":"M Lavin","year":"2016","unstructured":"Lavin M, Brophy TM, Rawley O, O\u2019Sullivan JM, Hayden PJ, Browne PV, Ryan K, O\u2019Connell N, O\u2019Donnell JS (2016) Lenalidomide as a\u00a0novel treatment for refractory acquired von Willebrand syndrome associated with monoclonal gammopathy. J\u00a0Thromb Haemost 14(6):1200\u20131205","journal-title":"J Thromb Haemost"},{"key":"4257_CR36","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0025-6196(11)65128-8","volume":"74","author":"D Rayson","year":"1999","unstructured":"Rayson D, Lust JA, Duncan A, Su WP (1999) Scleromyxedema: a\u00a0complete response to prednisone. Mayo Clin Proc 74:481\u2013484","journal-title":"Mayo Clin Proc"},{"key":"4257_CR37","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1346-8138.2006.00047.x","volume":"33","author":"YC Lin","year":"2006","unstructured":"Lin YC, Wang HC, Shen JL (2006) Scleromyxedema: an experience using treatment with systemic corticosteroid and review of the published work. J\u00a0Dermatol 33:207\u2013210","journal-title":"J Dermatol"},{"key":"4257_CR38","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.1016\/j.jaad.2004.03.023","volume":"51","author":"KB Horn","year":"2004","unstructured":"Horn KB, Horn MA, Swan J, Singhal S, Guitart J (2004) A complete and durable clinical response to high-dose dexamethasone in a\u00a0patient with scleromyxedema. J\u00a0Am Acad Dermatol 51:S120\u2013S123","journal-title":"J Am Acad Dermatol"},{"key":"4257_CR39","first-page":"1071","volume":"137","author":"AM Feasel","year":"2001","unstructured":"Feasel AM, Donato ML, Duvic M (2001) Complete remission of scleromyxedema following autologous stem cell transplantation. Arch Dermatol 137:1071\u20131072","journal-title":"Arch Dermatol"},{"issue":"5","key":"4257_CR40","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/j.1600-0609.2012.01772.x","volume":"88","author":"J Ca\u00f1ueto","year":"2012","unstructured":"Ca\u00f1ueto J, Labrador J, Rom\u00e1n C et\u00a0al (2012) The combination of bortezomib and dexamethasone is an efficient therapy for relapsed\/refractory scleromyxedema: a\u00a0rare disease with new clinical insights. Eur J Haematol 88(5):450\u2013454","journal-title":"Eur J Haematol"},{"issue":"11","key":"4257_CR41","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1007\/s00277-014-2065-5","volume":"93","author":"T Devos","year":"2014","unstructured":"Devos T, Thiessen S, Cuyle PJ, Meersseman W, Delforge M (2014) Long-term follow-up in a\u00a0patient with the dermato-neuro syndrome treated with high-dose melphalan, thalidomide, and intravenous immunoglobulins for more than 7 years. Ann Hematol 93(11):1927\u20131928","journal-title":"Ann Hematol"},{"issue":"2","key":"4257_CR42","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.trsl.2014.06.002","volume":"165","author":"N Shayegi","year":"2015","unstructured":"Shayegi N, Alakel N, Middeke JM, Schetelig J, Mantovani-L\u00f6ffler L, Bornh\u00e4user M (2015) Allogeneic stem cell transplantation for the treatment of refractory scleromyxedema. Transl Res 165(2):321\u2013324","journal-title":"Transl Res"},{"issue":"6","key":"4257_CR43","doi-asserted-by":"publisher","first-page":"e213","DOI":"10.1016\/j.clml.2014.06.018","volume":"14","author":"SR Shams","year":"2014","unstructured":"Shams SR, Goldstein DA, Kaufman JL, Mackelfresh J, Flowers CR, Langston AA (2014) Dermato-neuro syndrome in a\u00a0patient treated with autologous stem cell transplant for scleromyxedema. Clin Lymphoma Myeloma Leuk 14(6):e213\u2013e215","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"4257_CR44","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1182\/blood-2004-12-4870","volume":"107","author":"ML Donato","year":"2006","unstructured":"Donato ML, Feasel AM, Weber DM, Prieto VG, Giralt SA, Duvic M (2006) Scleromyxoedema: role of high-dose melphalan with autologous stem cell transplantation. Blood 107:463\u2013466","journal-title":"Blood"},{"issue":"10","key":"4257_CR45","doi-asserted-by":"publisher","first-page":"e539","DOI":"10.1111\/ijd.13315","volume":"55","author":"R Chockalingam","year":"2016","unstructured":"Chockalingam R, Duvic M (2016) Scleromyxedema: long-term follow-up after high-dose melphalan with autologous stem cell transplantation. Int J Dermatol 55(10):e539\u2013e543","journal-title":"Int J Dermatol"},{"key":"4257_CR46","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1111\/j.1365-2133.2007.08169.x","volume":"157","author":"P Gholam","year":"2007","unstructured":"Gholam P, Hartmann M, Enk A (2007) Arndt-Gottron scleromyxedema: successful therapy with intravenous immunoglobulins. Br J Dermatol 157:1058\u20131060","journal-title":"Br J Dermatol"},{"issue":"3","key":"4257_CR47","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1600-0781.2005.00154.x","volume":"21","author":"M Brenner","year":"2005","unstructured":"Brenner M, Herzinger T, Berking C, Plewig G, Degitz K (2005) Phototherapy and photochemotherapy of sclerosing skin diseases. Photodermatol Photoimmunol Photomed 21(3):157\u2013165","journal-title":"Photodermatol Photoimmunol Photomed"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-018-4257-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-018-4257-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-018-4257-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T23:31:57Z","timestamp":1566430317000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-018-4257-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,22]]},"references-count":47,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["4257"],"URL":"https:\/\/doi.org\/10.1007\/s00105-018-4257-8","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,22]]},"assertion":[{"value":"22 August 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0Neufeld, C.\u00a0Sunderk\u00f6tter und R.K.C.\u00a0Moritz geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren. Alle Patienten, die \u00fcber Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts zu identifizieren sind, haben hierzu ihre schriftliche Einwilligung gegeben. Im Falle von nicht m\u00fcndigen Patienten liegt die Einwilligung eines Erziehungsberechtigten oder des gesetzlich bestellten Betreuers vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}